Is Clinical Cancer Research Indexed in PubMed? Yes, and MEDLINE Is Active
Clinical Cancer Research is indexed in PubMed and currently indexed for MEDLINE, which helps translational oncology papers reach both laboratory and clinical readers.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: yes. Clinical Cancer Research is indexed in PubMed, and the NLM Catalog shows that it is currently indexed for MEDLINE.
Direct answer
If you publish in Clinical Cancer Research, your article is discoverable in PubMed and sits inside the active MEDLINE system used across biomedical literature.
The NLM record shows:
- publication history beginning in 1995
- active PubMed coverage
- active MEDLINE coverage
- current indexing status: Currently indexed for MEDLINE
- current subset: Index Medicus
That is the operational answer authors usually need: the journal is actively visible in the core biomedical search system.
Why this matters for Clinical Cancer Research
This journal sits at the lab-to-clinic boundary. Its best papers often need to reach:
- clinician-scientists
- translational oncology researchers
- biomarker and diagnostics groups
- therapy-response and resistance readers
- review authors working across laboratory and patient data
Those audiences often search by biomarker, therapy, subtype, resistance mechanism, or assay rather than by browsing a journal issue. PubMed indexing matters because it helps the paper reach that mixed translational audience naturally.
PubMed versus MEDLINE
For this journal, the distinction still helps:
- PubMed means the paper is discoverable in the search environment many oncology readers use first.
- MEDLINE means the journal is actively included in the curated NLM journal index.
For a translational title, that combination matters because the value of the paper often depends on being findable by both laboratory and clinically oriented readers.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether the manuscript is a strong fit for Clinical Cancer Research.
Indexing tells you the paper will be visible. It does not tell you whether the study makes a credible translational argument, whether the biomarker logic is mature enough, or whether the patient-facing consequence is strong enough for the journal.
That is why the better next reads are:
- Is Clinical Cancer Research a good journal?
- Clinical Cancer Research submission guide
- Clinical Cancer Research submission process
- Clinical Cancer Research acceptance rate
Practical verdict
Yes, Clinical Cancer Research is indexed in PubMed and currently indexed for MEDLINE. If your question is whether a published paper will be visible in the main translational-oncology search workflow, the answer is yes.
If your real question is whether the manuscript truly belongs in Clinical Cancer Research, that is a separate fit decision. A free Manusights scan is the best next step if you want that judgment before submission.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.